
New drug combinations could improve therapies for breast cancer, other aggressive cancers
OHSU study finds drug combinations slow progression of the cancer and lead to cancer regression.
Tom Sellers, M.D., M.P.H., newly announced director of the OHSU Knight Cancer Institute, introduces himself to the members of the institute. (OHSU).
OHSU patient Thomas Proctor, 49, of Aloha, Oregon, stretches while jogging a trail near his home. (OHSU/Christine Torres Hicks)